Cargando…
Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection
COVID-19 pandemic is spreading rapidly worldwide, and drug selection can affect the morbidity and mortality of the disease positively or negatively. Alpha-lipoic acid (ALA) is a potent antioxidant and reduces oxidative stress and inhibits activation of nuclear factor-kappa B (NF-kB). ALA reduces ADA...
Autores principales: | Cure, Erkan, Cumhur Cure, Medine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427590/ https://www.ncbi.nlm.nih.gov/pubmed/33017914 http://dx.doi.org/10.1016/j.mehy.2020.110185 |
Ejemplares similares
-
Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis
por: Cure, Erkan, et al.
Publicado: (2020) -
Colchicine may not be effective in COVID-19 infection; it may even be harmful?
por: Cumhur Cure, Medine, et al.
Publicado: (2020) -
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
por: Cure, Erkan, et al.
Publicado: (2020) -
COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets
por: Cure, Erkan, et al.
Publicado: (2020) -
NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection
por: Cumhur Cure, Medine, et al.
Publicado: (2020)